Imprimis Pharmaceuticals, Inc. (NASDAQ:IMMY) Files An 8-K Entry into a Material Definitive ...
Imprimis Pharmaceuticals, Inc. (Imprimis) is engaged in the development, production and dispensing of compounded pharmaceuticals. The Company ..